Skip to main content

5 Result(s)

within Ronald E. Gress Remove this filter Medicine & Public Health Remove this filter

and

  1. No Access

    Article

    Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia

    The only current curative treatment for chronic lymphocytic leukemia (CLL) is allogenic hematopoietic stem cell transplantation. Chimeric antigen receptor treatment targeting CD19 for CLL achieved some complet...

    Damian Kovalovsky, Jeong Heon Yoon, Matthew G. Cyr, Samantha Simon… in Leukemia (2021)

  2. No Access

    Article

    Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients

    In 2005, the National Institutes of Health (NIH) chronic graft-versus-host disease (cGVHD) consensus project provided diagnosis and staging criteria, based mostly on clinical experience and expert opinion. The...

    Ana Zelic Kerep, Jacob Broome, Filip Pirsl, Lauren M. Curtis… in Bone Marrow Transplantation (2019)

  3. No Access

    Chapter

    Immune Reconstitution and Implications for Immunotherapy Following Hematopoeitic Stem Cell Transplantation

    The innate immune system comprises a collection of cells that recognize and eradicate pathogens or aberrant cells without priming or antigen presentation. Natural killer cells, neutrophils, monocytes, dendriti...

    Kirsten M. Williams, Ronald E. Gress in Allogeneic Stem Cell Transplantation (2010)

  4. Article

    IMPAIRED IMMUNE RECONSTITUTION POST SEQUENTIAL HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL BLOOD PROGENITOR CELL (PBPC) INFUSION. † 962

    Dagmar T Stein, Crystal L Mackall, Catherine V Bare, Margaret R Brown… in Pediatric Research (1996)

    Download PDF (96 KB) View Article

  5. Article

    SKEWING OF THE T CELL REPERTOIRE TOWARD A TARGET ANTIGEN DURING A PERIOD OF T CELL IMMUNE RECONSTITUTION. • 935

    Crystal L Mackall, Ronald E Gress in Pediatric Research (1996)

    Download PDF (96 KB) View Article